Skip to content

Comprehension of medicine label instructions - a pilot study in glaucoma patients.

Are large print labels, on eye medications, required by glaucoma patient's to assist their comprehension of prescribed treatment?

Status
Completed
Phases
Phase 1
Study type
Interventional
Source
ANZCTR
Registry ID
ACTRN12607000248460
Enrollment
200
Registered
2007-05-08
Start date
2007-04-01
Completion date
Unknown
Last updated
2020-01-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Brief summary

Main purpose of this study is to identify if there is a need to offer of a large print label, on eye medications, to glaucoma patients that display certain visual function and disease characteristics. In turn, this may assist these patients in adhering to their prescribed treatment.

Interventions

Written informed consent will be obtained from all paricipants. Participants will have their near vision assessed with their usual correction / glasses. Thirdly, they will be asked to recall their own eye medication use; name, dose and instructions for use for each. Finally, they will be asked 3 repeat questions on 4 sample eye drop labels. The questions are structured to allow identification of "the name of the medicine", "which eye the medicine is for" and "how often the medicine should be

Written informed consent will be obtained from all paricipants. Participants will have their near vision assessed with their usual correction / glasses. Thirdly, they will be asked to recall their own eye medication use; name, dose and instructions for use for each. Finally, they will be asked 3 repeat questions on 4 sample eye drop labels. The questions are structured to allow identification of "the name of the medicine", "which eye the medicine is for" and "how often the medicine should be used". Answers will be recorded as either correct or incorrect. Participants will be presented 2 standard and 2 large print labels in a set format and permitted a few minutes to examine each before being questioned. Assessment time approximately 5-10 minutes.

Sponsors

Catherine Rokhahr, Pharmacy, Royal Victorian Eye and Ear Hospital.
Lead SponsorIndividual

Study design

Allocation
Non-randomised trial
Intervention model
Single group
Primary purpose
Educational / counselling / training
Masking
Open (masking not used)

Eligibility

Sex/Gender
All
Age
18 Years to 100 Years
Healthy volunteers
No

Inclusion criteria

Patients on any number of medication eye drops who have not had their eyes dilated in the pre-assessment clinic.

Exclusion criteria

Patients that do not speak English.

Outcome results

None listed

Source: ANZCTR · Data processed: Feb 4, 2026